{"id":56361,"date":"2025-07-30T08:51:50","date_gmt":"2025-07-30T08:51:50","guid":{"rendered":"https:\/\/ibima.eu\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\/"},"modified":"2025-07-30T08:51:50","modified_gmt":"2025-07-30T08:51:50","slug":"tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2","status":"publish","type":"post","link":"https:\/\/ibima.eu\/es\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\/","title":{"rendered":"Tratamiento antiplaquetario en s\u00edndromes coronarios agudos. Seguridad y eficacia del cambio de antiplaquetario. Seguridad y eficacia de Tricagrelor VS Clopidogrel en pacientes con s\u00edndrome coronario agudo.Antiplatelet treatment in acute coronary syndromes. safety and efficacy of antiplatelet switching. Safety and Efficacy of Ticagrelor vs Clopidogrel in Patients with Acute Coronary Syndrome"},"content":{"rendered":"<p>JOSE ANDRES ARBOLEDA SANCHEZ &#8211; ESTUDIO POSAUTORIZACION INDEPENDIENTE &#8211; No aplica &#8211; FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD M.P.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>JOSE ANDRES ARBOLEDA SANCHEZ &#8211; ESTUDIO POSAUTORIZACION INDEPENDIENTE &#8211; No aplica &#8211; FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD M.P.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2263,2303],"tags":[],"class_list":["post-56361","post","type-post","status-publish","format-standard","hentry","category-ensayos-clinicos","category-ensayos-clinicos-de-07-ensayos-clinicos"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tratamiento antiplaquetario en s\u00edndromes coronarios agudos. Seguridad y eficacia del cambio de antiplaquetario. Seguridad y eficacia de Tricagrelor VS Clopidogrel en pacientes con s\u00edndrome coronario agudo.Antiplatelet treatment in acute coronary syndromes. safety and efficacy of antiplatelet switching. Safety and Efficacy of Ticagrelor vs Clopidogrel in Patients with Acute Coronary Syndrome - Ibima<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/es\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tratamiento antiplaquetario en s\u00edndromes coronarios agudos. Seguridad y eficacia del cambio de antiplaquetario. Seguridad y eficacia de Tricagrelor VS Clopidogrel en pacientes con s\u00edndrome coronario agudo.Antiplatelet treatment in acute coronary syndromes. safety and efficacy of antiplatelet switching. Safety and Efficacy of Ticagrelor vs Clopidogrel in Patients with Acute Coronary Syndrome - Ibima\" \/>\n<meta property=\"og:description\" content=\"JOSE ANDRES ARBOLEDA SANCHEZ &#8211; ESTUDIO POSAUTORIZACION INDEPENDIENTE &#8211; No aplica &#8211; FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD M.P.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/es\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-30T08:51:50+00:00\" \/>\n<meta name=\"author\" content=\"prodriguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"prodriguez\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\\\/\"},\"author\":{\"name\":\"prodriguez\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"headline\":\"Tratamiento antiplaquetario en s\u00edndromes coronarios agudos. Seguridad y eficacia del cambio de antiplaquetario. Seguridad y eficacia de Tricagrelor VS Clopidogrel en pacientes con s\u00edndrome coronario agudo.Antiplatelet treatment in acute coronary syndromes. safety and efficacy of antiplatelet switching. Safety and Efficacy of Ticagrelor vs Clopidogrel in Patients with Acute Coronary Syndrome\",\"datePublished\":\"2025-07-30T08:51:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\\\/\"},\"wordCount\":73,\"commentCount\":0,\"articleSection\":[\"Ensayos Cl\u00ednicos\",\"Ensayos Cl\u00ednicos - DE-07\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\\\/\",\"name\":\"Tratamiento antiplaquetario en s\u00edndromes coronarios agudos. Seguridad y eficacia del cambio de antiplaquetario. Seguridad y eficacia de Tricagrelor VS Clopidogrel en pacientes con s\u00edndrome coronario agudo.Antiplatelet treatment in acute coronary syndromes. safety and efficacy of antiplatelet switching. Safety and Efficacy of Ticagrelor vs Clopidogrel in Patients with Acute Coronary Syndrome - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"datePublished\":\"2025-07-30T08:51:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tratamiento antiplaquetario en s\u00edndromes coronarios agudos. Seguridad y eficacia del cambio de antiplaquetario. Seguridad y eficacia de Tricagrelor VS Clopidogrel en pacientes con s\u00edndrome coronario agudo.Antiplatelet treatment in acute coronary syndromes. safety and efficacy of antiplatelet switching. Safety and Efficacy of Ticagrelor vs Clopidogrel in Patients with Acute Coronary Syndrome\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\",\"name\":\"prodriguez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"caption\":\"prodriguez\"},\"sameAs\":[\"https:\\\/\\\/ibima.eu\"],\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/author\\\/prodriguez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tratamiento antiplaquetario en s\u00edndromes coronarios agudos. Seguridad y eficacia del cambio de antiplaquetario. Seguridad y eficacia de Tricagrelor VS Clopidogrel en pacientes con s\u00edndrome coronario agudo.Antiplatelet treatment in acute coronary syndromes. safety and efficacy of antiplatelet switching. Safety and Efficacy of Ticagrelor vs Clopidogrel in Patients with Acute Coronary Syndrome - Ibima","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/es\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\/","og_locale":"es_ES","og_type":"article","og_title":"Tratamiento antiplaquetario en s\u00edndromes coronarios agudos. Seguridad y eficacia del cambio de antiplaquetario. Seguridad y eficacia de Tricagrelor VS Clopidogrel en pacientes con s\u00edndrome coronario agudo.Antiplatelet treatment in acute coronary syndromes. safety and efficacy of antiplatelet switching. Safety and Efficacy of Ticagrelor vs Clopidogrel in Patients with Acute Coronary Syndrome - Ibima","og_description":"JOSE ANDRES ARBOLEDA SANCHEZ &#8211; ESTUDIO POSAUTORIZACION INDEPENDIENTE &#8211; No aplica &#8211; FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD M.P.","og_url":"https:\/\/ibima.eu\/es\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\/","og_site_name":"Ibima","article_published_time":"2025-07-30T08:51:50+00:00","author":"prodriguez","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"prodriguez"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ibima.eu\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\/#article","isPartOf":{"@id":"https:\/\/ibima.eu\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\/"},"author":{"name":"prodriguez","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"headline":"Tratamiento antiplaquetario en s\u00edndromes coronarios agudos. Seguridad y eficacia del cambio de antiplaquetario. Seguridad y eficacia de Tricagrelor VS Clopidogrel en pacientes con s\u00edndrome coronario agudo.Antiplatelet treatment in acute coronary syndromes. safety and efficacy of antiplatelet switching. Safety and Efficacy of Ticagrelor vs Clopidogrel in Patients with Acute Coronary Syndrome","datePublished":"2025-07-30T08:51:50+00:00","mainEntityOfPage":{"@id":"https:\/\/ibima.eu\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\/"},"wordCount":73,"commentCount":0,"articleSection":["Ensayos Cl\u00ednicos","Ensayos Cl\u00ednicos - DE-07"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ibima.eu\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ibima.eu\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\/","url":"https:\/\/ibima.eu\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\/","name":"Tratamiento antiplaquetario en s\u00edndromes coronarios agudos. Seguridad y eficacia del cambio de antiplaquetario. Seguridad y eficacia de Tricagrelor VS Clopidogrel en pacientes con s\u00edndrome coronario agudo.Antiplatelet treatment in acute coronary syndromes. safety and efficacy of antiplatelet switching. Safety and Efficacy of Ticagrelor vs Clopidogrel in Patients with Acute Coronary Syndrome - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"datePublished":"2025-07-30T08:51:50+00:00","author":{"@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"breadcrumb":{"@id":"https:\/\/ibima.eu\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/tratamiento-antiplaquetario-en-sindromes-coronarios-agudos-seguridad-y-eficacia-del-cambio-de-antiplaquetario-seguridad-y-eficacia-de-tricagrelor-vs-clopidogrel-en-pacientes-con-sindrome-coronario-a-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"Tratamiento antiplaquetario en s\u00edndromes coronarios agudos. Seguridad y eficacia del cambio de antiplaquetario. Seguridad y eficacia de Tricagrelor VS Clopidogrel en pacientes con s\u00edndrome coronario agudo.Antiplatelet treatment in acute coronary syndromes. safety and efficacy of antiplatelet switching. Safety and Efficacy of Ticagrelor vs Clopidogrel in Patients with Acute Coronary Syndrome"}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635","name":"prodriguez","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","caption":"prodriguez"},"sameAs":["https:\/\/ibima.eu"],"url":"https:\/\/ibima.eu\/es\/author\/prodriguez\/"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts\/56361","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/comments?post=56361"}],"version-history":[{"count":0,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts\/56361\/revisions"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/media?parent=56361"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/categories?post=56361"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/tags?post=56361"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}